Hypoglycemia associated with fluoroquinolone: a pharmacovigilance analysis from 2014 to 2023 based on the FDA adverse event reporting system

Hypoglycemia associated with fluoroquinolone: a pharmacovigilance analysis from 2014 to 2023 based on the FDA adverse event reporting system

ObjectiveWith the increasing use of fluoroquinolones (FQs) for anti-infective therapy, the adverse events (AEs) caused by their collateral effects pose a key challenge in their clinical application. Hypoglycemia AEs are a type of AE linked to FQs and are commonly observed in real-world settings. Our...

Full description

Saved in:
Bibliographic Details
Main Authors: Dan Li, Yuan Zhang, Yu Qi Wang, Lei Cheng, Xiao Dan Zhou, Jia Chen, Guo Wen Feng, Ya Ling Chen, Yun Chen, Zi Xue Xuan, Li Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Medicine
Subjects:
FAERS
fluoroquinolones
disproportionality analysis
hypoglycemia
clinical characteristics
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1583093/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2025.1583093/full

Similar Items